16 results
PRE 14A
SYRS
Syros Pharmaceuticals Inc.
12 Apr 24
Preliminary proxy
4:30pm
, national origin, physical disability, or age, are empowered to achieve their full potential. The unique talents, backgrounds and perspectives of each … of the disability, death, termination or other cessation of employment or service, authorized leave of absence or other change in the employment or other
425
SYRS
Syros Pharmaceuticals Inc.
15 Sep 22
Business combination disclosure
4:08pm
and conditions in addition to those set forth in the Plan.
(c) Termination of Status. The Board shall determine the effect on an Award of the disability, death
8-K
EX-99.1
qjmixy95uh5y650su
15 Sep 22
Departure of Directors or Certain Officers
4:06pm
S-4
EX-10.5
c8togwb7xg6lsa
18 Jul 22
Registration of securities issued in business combination transactions
7:58am
425
xvjqg 009m
5 Jul 22
Business combination disclosure
7:14am
8-K
EX-2.1
uxw0p3ycs1nhlm
5 Jul 22
Syros to Raise Approximately $190 Million Through Merger with TYME Technologies and Concurrent Private Placement
7:07am
8-K
EX-10.2
624p7q72cxynmvtonz
13 Oct 21
Departure of Directors or Certain Officers
4:01pm
8-K
EX-2.1
i5ra8a eptetku7d6w
7 Dec 20
Entry into a Material Definitive Agreement
6:05am
8-K
EX-1.1
hbo9r7h9ywkdx 8qar4
13 Feb 20
Syros Announces $60 Million Loan Facility with Oxford Finance LLC
8:51am
- Prev
- 1
- Next